Master regulators of FGFR2 signalling and breast cancer risk
about
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskStroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Limited evidence that cancer susceptibility regions are preferential targets for somatic mutationFine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors.Reverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerIncorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology AnalysisA Gene Regulatory Program in Human Breast CancerRegulators of genetic risk of breast cancer identified by integrative network analysis.Sense-antisense gene-pairs in breast cancer and associated pathological pathways.The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements.The recurrent architecture of tumour initiation, progression and drug sensitivity.Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3.Gene signature driving invasive mucinous adenocarcinoma of the lung.Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia.HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics.Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.Integrated Theory- and Data-driven Feature Selection in Gene Expression Data Analysis.Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway.Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.REGGAE: a novel approach for the identification of key transcriptional regulators
P2860
Q26799669-E46E1110-610B-4D09-B9A0-56EDAA0C5F39Q27307642-F0756992-E0B0-496B-960A-1CE29ED945D4Q34494290-C2168574-2E71-4435-8E54-08C59B3645CCQ34903062-16C736DF-FE4D-47AA-9487-915D2043E924Q34992813-A81FB3D5-D22D-4B6D-98DF-BB8E3FD94E67Q35070297-5BC6B538-E9C9-4C5F-9B70-F1D33C570C08Q35619119-782C8E65-4032-45C3-8508-E5B2B6BF788FQ35782435-D82E0891-9166-4CF5-9E07-6D13EC6F69FBQ35796865-81C42253-3C87-4B2B-A902-A23891F62BFDQ35852820-3329BB98-C446-48D8-9238-1F51EB38F088Q36229602-EEBDD37B-8681-4AD6-BFAF-3C0E736B8191Q36264967-3FE41D53-8439-46EA-AD74-D3B062FB9392Q36365236-C4F070DD-6DBA-47F4-9512-41EF639C08ABQ36419747-C2EBB977-97CB-4F6D-9DC2-715AF6D09321Q36561721-A6C038F7-464E-47DC-9E7E-F1CD44D2F8C2Q36754900-F247071B-FE62-4EB6-BE60-0A2FDAFCA24BQ37139660-A91B6CEB-3A27-4AA0-919E-5ABDAA466727Q37605645-9A65ED90-B67D-42FB-99B2-587CABE6CD63Q37711615-1C80FC7E-ECDC-49A0-AF19-E48F1751DF7EQ38720533-BA40187E-B775-4F08-9266-261737B21481Q38725396-5CB86243-B4B9-4568-B599-61EB944A6EC4Q39039006-699C10E4-71AE-47B9-8F05-B8F9AE68C325Q39560851-F1F40700-6D1C-4F4E-AFCE-AD2D873E82F2Q39752527-557AFA25-7A1E-4172-9139-845F01351952Q39779714-7F85968F-95DC-412F-BE71-F0AACE921671Q42293061-222E3F7C-4A27-40F5-A897-82ED045AFCFCQ42516513-E25A8A43-96D3-4F84-AEF0-B405AACCB073Q46382588-494B441A-2AFD-4AE1-BC2E-596BA34890E3Q47134720-D7914F20-42DA-409F-86A5-C9C1AD5925DBQ47295042-0913699C-40DA-4977-8890-45C261CFFD27Q47708657-1F8327A6-E2C8-4908-A211-51C4BEC7D55AQ48607061-32C9E382-F57F-4487-801B-C10F07E0B784Q49727374-54E5A6F6-1557-4904-82C1-1889402AFE08Q52571267-3E4702A4-695F-4B95-888B-4F6E01B3F476Q55499595-5DC545B8-39E3-4664-AE53-F00A30DD50AEQ57461511-36A1E24B-1DD8-4DC3-9D90-88DC607A2FD7
P2860
Master regulators of FGFR2 signalling and breast cancer risk
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Master regulators of FGFR2 signalling and breast cancer risk
@en
Master regulators of FGFR2 signalling and breast cancer risk.
@nl
type
label
Master regulators of FGFR2 signalling and breast cancer risk
@en
Master regulators of FGFR2 signalling and breast cancer risk.
@nl
prefLabel
Master regulators of FGFR2 signalling and breast cancer risk
@en
Master regulators of FGFR2 signalling and breast cancer risk.
@nl
P2093
P2860
P50
P356
P1476
Master regulators of FGFR2 signalling and breast cancer risk
@en
P2093
Bruce A J Ponder
Kerstin B Meyer
Martin O'Reilly
Mauro A A Castro
Michael N C Fletcher
Oscar M Rueda
P2860
P2888
P356
10.1038/NCOMMS3464
P407
P577
2013-01-01T00:00:00Z